138 related articles for article (PubMed ID: 38896305)
21. Inherited p40phox deficiency differs from classic chronic granulomatous disease.
van de Geer A; Nieto-Patlán A; Kuhns DB; Tool AT; Arias AA; Bouaziz M; de Boer M; Franco JL; Gazendam RP; van Hamme JL; van Houdt M; van Leeuwen K; Verkuijlen PJ; van den Berg TK; Alzate JF; Arango-Franco CA; Batura V; Bernasconi AR; Boardman B; Booth C; Burns SO; Cabarcas F; Bensussan NC; Charbit-Henrion F; Corveleyn A; Deswarte C; Azcoiti ME; Foell D; Gallin JI; Garcés C; Guedes M; Hinze CH; Holland SM; Hughes SM; Ibañez P; Malech HL; Meyts I; Moncada-Velez M; Moriya K; Neves E; Oleastro M; Perez L; Rattina V; Oleaga-Quintas C; Warner N; Muise AM; López JS; Trindade E; Vasconcelos J; Vermeire S; Wittkowski H; Worth A; Abel L; Dinauer MC; Arkwright PD; Roos D; Casanova JL; Kuijpers TW; Bustamante J
J Clin Invest; 2018 Aug; 128(9):3957-3975. PubMed ID: 29969437
[TBL] [Abstract][Full Text] [Related]
22. Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.
Chandrasekaran P; Han Y; Zerbe CS; Heller T; DeRavin SS; Kreuzberg SA; Marciano BE; Siu Y; Jones DR; Abraham RS; Stephens MC; Tsou AM; Snapper S; Conlan S; Subramanian P; Quinones M; Grou C; Calderon V; Deming C; Leiding JW; Arnold DE; Logan BR; Griffith LM; Petrovic A; Mousallem TI; Kapoor N; Heimall JR; Barnum JL; Kapadia M; Wright N; Rayes A; Chandra S; Broglie LA; Chellapandian D; Deal CL; Grunebaum E; Lim SS; Mallhi K; Marsh RA; Murguia-Favela L; Parikh S; Touzot F; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Kang EM; Malech HL; Segre JA; Bryant CE; Holland SM; Falcone EL
J Allergy Clin Immunol; 2023 Dec; 152(6):1619-1633.e11. PubMed ID: 37659505
[TBL] [Abstract][Full Text] [Related]
23. Regulatory T cell features in chronic granulomatous disease.
van de Geer A; Cuadrado E; Slot MC; van Bruggen R; Amsen D; Kuijpers TW
Clin Exp Immunol; 2019 Aug; 197(2):222-229. PubMed ID: 30924925
[TBL] [Abstract][Full Text] [Related]
24. Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical Exemplar.
Donko A; Kuhns DB; Cousin MA; Smith MJ; Sacco KA; Klee EW; Joshi AY; Gavrilova RH; Holland SM; Leto TL; Abraham RS
J Clin Immunol; 2022 Jul; 42(5):986-999. PubMed ID: 35344128
[TBL] [Abstract][Full Text] [Related]
25. A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.
Ben-Farhat K; Ben-Mustapha I; Ben-Ali M; Rouault K; Hamami S; Mekki N; Ben-Chehida A; Larguèche B; Fitouri Z; Abdelmoula S; Khemiri M; Guediche MN; Boukthir S; Barsaoui S; Chemli J; Barbouche MR
J Clin Immunol; 2016 Aug; 36(6):547-54. PubMed ID: 27220316
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).
Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Wolach O; Grisaru-Soen G; Broides A; Etzioni A; Somech R; Roos D
J Clin Immunol; 2018 Feb; 38(2):193-203. PubMed ID: 29411231
[TBL] [Abstract][Full Text] [Related]
27. "Clinical Aspects of Chronic Granulomatous Disease in Upper Egypt".
El-Mokhtar MA; Salama EH; Fahmy EM; Mohamed ME
Immunol Invest; 2021 Feb; 50(2-3):139-151. PubMed ID: 31965875
[TBL] [Abstract][Full Text] [Related]
28. Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
Mortaz E; Azempour E; Mansouri D; Tabarsi P; Ghazi M; Koenderman L; Roos D; Adcock IM
Int Arch Allergy Immunol; 2019; 179(1):62-73. PubMed ID: 30904913
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.
Akar HT; Esenboga S; Cagdas D; Halacli SO; Ozbek B; van Leeuwen K; de Boer M; Tan CS; Köker Y; Roos D; Tezcan I
J Clin Immunol; 2021 Jul; 41(5):992-1003. PubMed ID: 33629196
[TBL] [Abstract][Full Text] [Related]
30. Clinical, Immunological, and Molecular Profile of Chronic Granulomatous Disease: A Multi-Centric Study of 236 Patients From India.
Rawat A; Vignesh P; Sudhakar M; Sharma M; Suri D; Jindal A; Gupta A; Shandilya JK; Loganathan SK; Kaur G; Chawla S; Patra PK; Khadwal A; Saikia B; Minz RW; Aggarwal V; Taur P; Pandrowala A; Gowri V; Desai M; Kulkarni M; Hule G; Bargir U; Kambli P; Madkaikar M; Bhattad S; Ginigeri C; Kumar H; Jayaram A; Munirathnam D; Sivasankaran M; Raj R; Uppuluri R; Na F; George B; Lashkari HP; Kalra M; Sachdeva A; Seth S; Sabui T; Gupta A; van Leeuwen K; de Boer M; Chan KW; Imai K; Ohara O; Nonoyama S; Lau YL; Singh S
Front Immunol; 2021; 12():625320. PubMed ID: 33717137
[TBL] [Abstract][Full Text] [Related]
31. Recent topics and advanced therapies in chronic granulomatous disease.
Nunoi H; Nakamura H; Nishimura T; Matsukura M
Hum Cell; 2023 Mar; 36(2):515-527. PubMed ID: 36534309
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
[TBL] [Abstract][Full Text] [Related]
33. Hemophagocytic Lymphohistiocytosis in Children with Chronic Granulomatous Disease-Single-Center Experience from North India.
Vignesh P; Loganathan SK; Sudhakar M; Chaudhary H; Rawat A; Sharma M; Shekar A; Vaiphei K; Kumar N; Singh Sachdeva MU; Jindal AK; Suri D; Gupta A; Ray P; Imai K; Ohara O; Nonoyama S; Lau YL; Singh S
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):771-782.e3. PubMed ID: 33259975
[TBL] [Abstract][Full Text] [Related]
34. Genetics and immunopathology of chronic granulomatous disease.
Stasia MJ; Li XJ
Semin Immunopathol; 2008 Jul; 30(3):209-35. PubMed ID: 18509647
[TBL] [Abstract][Full Text] [Related]
35. Molecular diagnosis of chronic granulomatous disease.
Roos D; de Boer M
Clin Exp Immunol; 2014 Feb; 175(2):139-49. PubMed ID: 24016250
[TBL] [Abstract][Full Text] [Related]
36. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
[TBL] [Abstract][Full Text] [Related]
37. Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: a case report.
Valentine G; Thomas TA; Nguyen T; Lai YC
Pediatrics; 2014 Dec; 134(6):e1727-30. PubMed ID: 25422023
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients.
Gul I; Khan TA; Akbar NU; Gul N; Ali R; Khan SN
Ital J Pediatr; 2023 Aug; 49(1):95. PubMed ID: 37533075
[TBL] [Abstract][Full Text] [Related]
39. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
[TBL] [Abstract][Full Text] [Related]
40. Variant Type X91
Sun B; Zhu Z; Hui X; Sun J; Wang W; Ying W; Zhou Q; Yao H; Hou J; Wang X
J Clin Immunol; 2022 Oct; 42(7):1564-1579. PubMed ID: 35796921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
